Skip to main content
Log in

TAK 218

  • Section 1: Neuroprotection in Stroke
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ohkawa S, Fukatsu K, Miki S, et al. 5-Aminocoumarans: synthesis and protective effects against central nervous system trauma and ischemia [abstr. MEDI 011 (Poster)]. 14th American Chemical Society National Meeting: 1997 Sep 7

    Google Scholar 

  2. Iwama T, Hashimoto T, Nagai Y. Inhibitory effects of TAK-218, a novel neuroprotective candidate, on voltage-sensitive sodium currents in cultured rat hippocampal neurons. Japanese Journal of Pharmacology 1997; 73 Suppl. I: 85

    Google Scholar 

  3. Ohkawa S, Fukatsu K, Miki S, et al. 5-Aminocoumarans: dual inhibitors of lipid peroxidation and dopamine release with protective effects against central nervous system trauma and ischemia. J Med Chem 1997 Feb 14; 40: 559–73

    Article  PubMed  CAS  Google Scholar 

  4. Kiyota Y, Nakai Y, Hamajyo K, et al. Acute changes in diffusion-weighted magnetic resonance images following focal brain ischemia and protective effects of a novel neuroprotectant, TAK-218. Jpn J Pharmacol 1996; 71 Suppl. I: 172

    Google Scholar 

  5. Kito G, Hashimoto T, Imanishi M, et al. Effect of TAK-218 on the neurologic and histopathologic outcome after experimental thromboembolic stroke in dogs. Jpn J Pharmacol 1996; 71 Suppl. I: 172

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

TAK 218. Drugs R&D 1, 38–39 (1999). https://doi.org/10.2165/00126839-199901010-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901010-00015

Keywords

Navigation